All Stories

  1. Antibody-Mediated Serum Resistance Protects Pseudomonas aeruginosa During Bloodstream Infections

    Article • The Journal of Infectious Diseases, January 2024, Oxford University Press (OUP)

    Kate McCarthy

  2. Determining Pneumocystis jirovecii Colonisation from Infection Using PCR-Based Diagnostics in HIV-Negative Individuals

    Article • Diagnostics, January 2024, MDPI AG

    Kate McCarthy

  3. Comparing the use of midline catheters versus peripherally inserted central catheters for patients requiring peripherally compatible therapies: A pilot randomised controlled trial (the compact trial)

    Article • Infection Disease & Health, November 2023, Elsevier

    Kate McCarthy

  4. Feasibility of individualised patient modelling for continuous vancomycin infusions in outpatient antimicrobial therapy, a retrospective study

    Article • International Journal of Clinical Pharmacy, August 2023, Springer Science + Business Media

    Kate McCarthy

  5. State of the art: Intrapartum antibiotics in cesarean section, the infant microbiota and allergic diseases

    Article • Acta Obstetricia Et Gynecologica Scandinavica, April 2023, Wiley

    Kate McCarthy

  6. A contemporary case series of Pseudomonas aeruginosa infective endocarditis

    Article • Medicine, March 2023, Wolters Kluwer Health

    Kate McCarthy

  7. COVID‐19 (Omicron strain) hospital admissions from a virtual ward – who required further care?

    Article • Influenza and Other Respiratory Viruses, March 2023, Wiley

    Kate McCarthy

  8. Outcomes of octogenarians and nonagenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study

    Article • Infection, December 2022, Springer Science + Business Media

    Kate McCarthy

  9. Use of home pulse oximetry to enhance remote COVID-19 monitoring: Evaluating a single centre experience

    Article • November 2022, Cold Spring Harbor Laboratory Press

    Kate McCarthy

  10. COVID-19 (Omicron strain) hospital admissions from a virtual ward – who required further care?

    Article • November 2022, Cold Spring Harbor Laboratory Press

    Kate McCarthy

  11. Rapid fluoroquinolone resistance detection in Pseudomonas aeruginosa using mismatch amplification mutation assay-based real-time PCR

    Article • Journal of Medical Microbiology, October 2022, Society for General Microbiology

    Kate McCarthy

  12. Infection control behaviours, intra‐household transmission and quarantine duration: a retrospective cohort analysis of COVID‐19 cases

    Article • Australian and New Zealand Journal of Public Health, August 2022, Wiley

    Kate McCarthy

  13. Evaluating Mono- and Combination Therapy of Meropenem and Amikacin against Pseudomonas aeruginosa Bacteremia in the Hollow-Fiber Infection Model

    Article • Microbiology Spectrum, June 2022, ASM Journals

    Kate McCarthy

  14. Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study

    Article • Infectious Diseases and Therapy, May 2022, Springer Science + Business Media

    Kate McCarthy

  15. Evaluating mono and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the Hollow-Fiber Infection Model

    Article • December 2021, Cold Spring Harbor Laboratory Press

    Kate McCarthy

  16. Rapid fluoroquinolone resistance detection in Pseudomonas aeruginosa using mismatch amplification mutation assay-based real-time PCR

    Article • December 2021, Cold Spring Harbor Laboratory Press

    Kate McCarthy

  17. The MOBILISE study: utilisation of ambulatory pumps in the inpatient setting to administer continuous antibiotic infusions—a randomised controlled trial

    Article • European Journal of Clinical Microbiology & Infectious Diseases, July 2021, Springer Science + Business Media

    Kate McCarthy

  18. Case report: Ganoderma weberianum invasive fungal disease (IFD) during allogeneic hematopoietic stem cell transplantation (HSCT)

    Article • Transplant Infectious Disease, June 2021, Wiley

    Kate McCarthy

  19. Listeria monocytogenes brain abscess as a late complication of allogeneic haemopoietic stem cell transplantation

    Article • Internal Medicine Journal, June 2021, Wiley

    Kate McCarthy

  20. Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study

    Article • Journal of Antimicrobial Chemotherapy, May 2021, Oxford University Press (OUP)

    Kate McCarthy

  21. Erratum to: Plasma concentrations resulting from continuous infusion of meropenem in a community-based outpatient program: A case series

    Article • American Journal of Health-System Pharmacy, April 2021, Oxford University Press (OUP)

    Kate McCarthy

  22. Plasma concentrations resulting from continuous infusion of meropenem in a community-based outpatient program: A case series

    Article • American Journal of Health-System Pharmacy, December 2020, Oxford University Press (OUP)

    Kate McCarthy

  23. Septic arthritis post anterior cruciate ligament reconstruction due to Clostridioides difficile

    Article • Anaerobe, December 2020, Elsevier

    Kate McCarthy

  24. Contemporaneous management of ampicillin infusions in the outpatient setting through the use of therapeutic drug monitoring

    Article • International Journal of Antimicrobial Agents, June 2020, Elsevier

    Kate McCarthy

  25. Oral or intravenous antibiotics?

    Article • Australian Prescriber, April 2020, NPS MedicineWise

    Kate McCarthy

  26. Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study

    Article • International Journal of Antimicrobial Agents, February 2020, Elsevier

    Kate McCarthy

  27. Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective Study

    Article • Clinical Infectious Diseases, July 2019, Oxford University Press (OUP)

    Kate McCarthy

  28. Outcomes of patients with a history of injecting drug use and receipt of outpatient antimicrobial therapy

    Article • European Journal of Clinical Microbiology & Infectious Diseases, January 2019, Springer Science + Business Media

    Kate McCarthy

  29. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia

    Article • Pathology, December 2018, Elsevier

    Kate McCarthy

  30. P. aeruginosa blood stream infection isolates: A “full house” of virulence genes in isolates associated with rapid patient death and patient survival

    Article • Microbial Pathogenesis, June 2018, Elsevier

    Kate McCarthy

  31. Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat a carbapenem-resistant Pseudomonas Aeruginosa lung abscess on an outpatient antimicrobial program

    Article • International Journal of Antimicrobial Agents, June 2018, Elsevier

    Kate McCarthy

  32. A contemporary 16-year review of Coxiella burnetii infective endocarditis in a tertiary cardiac center in Queensland, Australia

    Article • Infectious Diseases, March 2018, Taylor & Francis

    Kate McCarthy

  33. Combination antibiotic therapy for Pseudomonas aeruginosa bacteremia in febrile neutropenic patients? The question still remains

    Article • Infectious Diseases, December 2017, Taylor & Francis

    Kate McCarthy

  34. Pseudomonas aeruginosa blood stream infection isolates from patients with recurrent blood stream infection: Is it the same genotype?

    Article • Epidemiology and Infection, August 2017, Cambridge University Press

    Kate McCarthy

  35. Draft Genome Sequences of Two Pseudomonas aeruginosa Bloodstream Infection Isolates Associated with Rapid Patient Death

    Article • Genome Announcements, August 2017, ASM Journals

    Kate McCarthy

  36. Draft Genome Sequence of an IMP-7-Producing Pseudomonas aeruginosa Bloodstream Infection Isolate from Australia

    Article • Genome Announcements, July 2017, ASM Journals

    Kate McCarthy

  37. Increased risk of death with recurrent Pseudomonas aeruginosa bacteremia

    Article • Diagnostic Microbiology and Infectious Disease, June 2017, Elsevier

    Kate McCarthy

  38. Long-term mortality following Pseudomonas aeruginosa bloodstream infection

    Article • Journal of Hospital Infection, March 2017, Elsevier

    Kate McCarthy

  39. Molecular epidemiology of Pseudomonas aeruginosa bloodstream infection isolates in a non-outbreak setting

    Article • Journal of Medical Microbiology, February 2017, Society for General Microbiology

    Kate McCarthy

  40. Community-acquired Pseudomonas aeruginosa bloodstream infection: a classification that should not falsely reassure the clinician

    Article • European Journal of Clinical Microbiology & Infectious Diseases, December 2016, Springer Science + Business Media

    Kate McCarthy

  41. The importance of bacterial lysis for the reliable detection of carbapenemase activity.

    Article • Journal of Microbiological Methods, December 2016, Elsevier

    Kate McCarthy, Hosam Zowawi, Dr Charlotte Anna Preston-Huber

  42. Pseudomonas aeruginosa: Evolution of Antimicrobial Resistance and Implications for Therapy

    Article • Seminars in Respiratory and Critical Care Medicine, February 2015, Thieme Publishing Group

    Kate McCarthy

  43. Successful treatment of post-neurosurgical intracranial Mycoplasma hominis infection using gatifloxacin

    Article • Journal of Infection, October 2008, Elsevier

    Kate McCarthy

  44. Severe Photosensitivity Causing Multifocal Squamous Cell Carcinomas Secondary to Prolonged Voriconazole Therapy

    Article • Clinical Infectious Diseases, March 2007, Oxford University Press (OUP)

    Kate McCarthy

  45. Pseudomonas aeruginosa blood stream infections: clinical and molecular epidemiology, virulence and outcome

    Article • University of Queensland Library

    Kate McCarthy